DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Philip PA et al.
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
J Clin Oncol 2005;
23 (27) 6657-6663
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.